BOCA RATON, Fla., July 24, 2024 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the second quarter ended June 30, 2024, after the market closes on Wednesday, August 7, 2024.
Management will host a conference call and audio webcast on Wednesday, August 7, 2024, at 4:30 p.m. ET to discuss the Company’s financial results.
| Event: | Second Quarter 2024 Financial Results Conference Call |
| Date: | Wednesday, August 7, 2024 |
| Time: | 4:30 p.m. Eastern Time |
| Live Call: | 1-877-407-0792 (U.S. & Canada Toll-Free) |
| Conference ID | 13747162 |
| Webcast: | Register |
For interested individuals unable to join the conference call, a webcast of the call will be available for one month following the call and can be accessed via webcast on Jushi’s Investor Relations website.
About Jushi Holdings Inc.
We are a vertically integrated cannabis company led by an industry-leading management team. Jushi is focused on building a multi-state portfolio of branded cannabis assets through opportunistic acquisitions, distressed workouts, and competitive applications. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem. For more information, visit jushico.com or our social media channels, Instagram, Facebook, X, and LinkedIn.
For further information, please contact:
Jushi Investor Relations
561-617-9100
investors@jushico.com


Đề xuất
From Product Exports to Global Standards: Feng Xingya Outlines the Next Stage of China’s Auto Globalization
GAC Chairman Highlights “Standards Going Global” to Drive High-Quality Overseas Expansion
Global Times: Understanding ‘people’ at the heart of Healthy China
MIFF 2026 AWARDS HONOUR DESIGN EXCELLENCE IN THE FURNITURE INDUSTRY
Bybit Announces Departure of Co-CEO Helen Liu as She Embarks on Entrepreneurial Journey
MagnesiumFreeze Sciatic Nerve Claims Evaluated: Consumer Research Report Examines Magnesium Niacinamide Relief Topical Cream Ingredients, NAD+ Science, and Sciatic Nerve Support Discussions